iLeukon Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch iLeukon Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| ILKN421H Plus Pembrolizumab in Advanced Non-Small Cell Lung Cancer (NCT07452224) | iLeukon Therapeutics, Inc. | 2026-06-29 |
Track iLeukon Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.